Here’s whether Johnson & Johnson (JNJ) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.47% over 10 days); RSI 54 — healthy momentum range; strong 1-year return of +55.3%; 3-month momentum positive (+15.8%). Currently 2.2% off its 52-week high. Score: +7/7.
JNJ is in a confirmed uptrend, trading above both its 50-day ($241.93) and 200-day ($224.64) moving averages. An RSI of 53.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +55.3% compares to +16.5% for SPY (beat the market by 38.9%).
$10,000 invested 1 year ago→ $15,534 today
vs. S&P 500 (SPY) — same period beat market by 38.9%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($224.64)
✓Above 50-day MA ($241.93)
✓RSI(14) neutral zone (30–70) — currently 53.7
✓Positive return (+55.3%)
✓Within 10% of period high (−2.2%)
Period Range $263.40
$164.23$269.43
RSI (14) 53.7
0 · OversoldOverbought · 100
Key Metrics
Price$263.40
Period Return+55.3%
Period High$269.43
Period Low$164.23
Drawdown−2.2%
MA-50$241.93
MA-200$224.64
RSI (14)53.7
Avg Volume (30d)8.8M
vs. SPYbeat by 38.9%
Return Rank#191 of 999
Trend Signals
Price is above the 200-day moving average ($224.64)
Price is above the 50-day moving average ($241.93)